We have specialist intellectual property (IP) teams in the most important IP jurisdictions worldwide.
With over 100 specialist IP partners and associates, we offer an integrated, cross-border service to meet our clients global needs, and provide specialist advice and representation in individual countries.
News & Insights
Publications: 21 JANUARY 2020
Brand owners and inventors tend to be up to speed on trademarks and patents which can lead to the design rights being left behind. Insufficient knowledge of the system and how it works is contributing to the lack of design filings and enforcement. Global Head of IP David Stone talks about the things that are in place to change this, including building an awareness of what design rights business owners have available to them.Lesen Sie mehr
News: 27 MARCH 2020
Allen & Overy hat One Peak bei seinem Investment in DataGuard, einen führenden europäischen Anbieter von Datenschutz, Compliance und IT-Sicherheit, beraten.Lesen Sie mehr
Publications: 29 JANUARY 2020
Today, the Court of Justice of the EU (CJEU) in Sky v SkyKick (C-371/18) has declined to follow the Advocate General and held that trade mark specifications that cover broad terms such as “computer software” cannot be invalidated on the basis that they are imprecise or contrary to public policy.Lesen Sie mehr
Publications: 16 MARCH 2020
Zur Eindämmung des Coronavirus haben Bund und Länder einschneidende Maßnahmen beschlossen. Was gilt derzeit in Deutschland, womit ist in den nächsten Tagen zu rechnen, und welche Maßnahmen ergreift die Bundesregierung zur Unterstützung der Wirtschaft?Lesen Sie mehr
Download the practice brochure
Allen & Overy is one of the few major global law firms with a full-service, cross-border intellectual property capability.
Life Sciences Hub
Legal and regulatory developments in the Life Sciences sector.
Focusing on the latest digital trends and risks and developments in the field of data protection, privacy, information and cyber law.
CRISPR is one of the most powerful and ground breaking advances in the history of biotechnology.